Browsing: Viral > HIV / AIDS
All epidemically successful HIV groups started to spread in early 20th century, this perspective piece looks into the factors that enabled adaptation of SIV to be sexually transmitted among humans.
Researchers have studied macaque models of antiretroviral-treated HIV, discovering a unique pattern of inflammation that may underlie neurological impairments.
Researchers have investigated the safety and virologic effect of an HIV booster vaccine in infected individuals on antiretroviral therapy during acute or early infection. Although no beneficial effects were determined, the study provides much needed insights for future efforts.
On the occasion of World AIDS Day 2017, the ISNTD is launching the disease report: “Female Genital Schistosomiasis: the most neglected gynaecological disease”, highlighting the linkages with HIV and calling for accelerating advocacy, policy and intervention collaboration.
In this World AIDS Day interview we speak to Richard Koup, who was recently an author on a study reporting a trispecific antibody able to target 99% of HIV strains.
To date there have only been a handful of Phase III efficacy trials for HIV vaccine candidates, which have had varied, and in some cases controversial, results. Here we review the history of HIV vaccine efficacy studies and look into the vaccine candidates closest to front-line use.
The FDA has approved Juluca®, the first two-drug regimen for maintenance treatment of HIV infection in adults, with the hope of presenting additional treatment options and lessening the burden on HIV-infected adults.